BRETT CARTER to Biomarkers, Tumor
This is a "connection" page, showing publications BRETT CARTER has written about Biomarkers, Tumor.
Connection Strength
0.072
-
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother. 2020 Aug; 69(8):1519-1534.
Score: 0.048
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med. 2021 03; 27(3):504-514.
Score: 0.013
-
Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. J Am Coll Radiol. 2020 Jan; 17(1 Pt A):22-30.
Score: 0.011